Exact Mass: 471.2232
Exact Mass Matches: 471.2232
Found 500 metabolites which its exact mass value is equals to given mass value 471.2232
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PUROMYCIN
An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors D009676 - Noxae > D000963 - Antimetabolites C784 - Protein Synthesis Inhibitor D000970 - Antineoplastic Agents KEIO_ID P075; [MS2] KO009213 KEIO_ID P075
Dabigatran
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2H-1-Benzopyran-7-ol, 3-(4-methoxyphenyl)-4-((4-(2-(1-piperidinyl)ethoxy)phenyl)methyl)-
Dabigatran
C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173066 - Direct Thrombin Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
5'-Guanidinonaltrindole
3-[3-Tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors
puromycin
Zanubrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents D006401 - Hematologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(13R)-6alpha,7beta-dihydroxy-8beta,13-epoxy-11beta-nicotinyloxy-ent-clerodan-3-en-15,16-olide|scutelinquanine D
Fluprostenol methyl amide
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-Alpha,Alpha-dimethyl-5-(1-methylethyl)- [CAS]
Ala Glu Pro Arg
Ala Glu Arg Pro
Ala Pro Glu Arg
Ala Pro Arg Glu
Ala Pro Val Trp
Ala Pro Trp Val
Ala Arg Glu Pro
Ala Arg Pro Glu
Ala Val Pro Trp
Ala Val Trp Pro
Ala Trp Pro Val
Ala Trp Val Pro
Cys Gly His Arg
Cys Gly Arg His
Cys His Gly Arg
Cys His Arg Gly
Cys Pro Pro Arg
Cys Pro Arg Pro
Cys Arg Gly His
Cys Arg His Gly
Cys Arg Pro Pro
Asp Ile Pro Gln
Asp Ile Gln Pro
Asp Leu Pro Gln
Asp Leu Gln Pro
Asp Pro Ile Gln
Asp Pro Leu Gln
Asp Pro Gln Ile
Asp Pro Gln Leu
Asp Gln Ile Pro
Asp Gln Leu Pro
Asp Gln Pro Ile
Asp Gln Pro Leu
Glu Ala Pro Arg
Glu Ala Arg Pro
Glu Ile Asn Pro
Glu Ile Pro Asn
Glu Leu Asn Pro
Glu Leu Pro Asn
Glu Asn Ile Pro
Glu Asn Leu Pro
Glu Asn Pro Ile
Glu Asn Pro Leu
Glu Pro Ala Arg
Glu Pro Ile Asn
Glu Pro Leu Asn
Glu Pro Asn Ile
Glu Pro Asn Leu
Glu Pro Gln Val
Glu Pro Arg Ala
Glu Pro Val Gln
Glu Gln Pro Val
Glu Gln Val Pro
Glu Arg Ala Pro
Glu Arg Pro Ala
Glu Val Pro Gln
Glu Val Gln Pro
Gly Cys His Arg
Gly Cys Arg His
Gly His Cys Arg
Gly His Lys Met
Gly His Met Lys
Gly His Arg Cys
Gly Ile Pro Trp
Gly Ile Trp Pro
Gly Lys His Met
Gly Lys Met His
Gly Leu Pro Trp
Gly Leu Trp Pro
Gly Met His Lys
Gly Met Lys His
Gly Pro Ile Trp
Gly Pro Leu Trp
Gly Pro Trp Ile
Gly Pro Trp Leu
Gly Arg Cys His
Gly Arg His Cys
Gly Trp Ile Pro
Gly Trp Leu Pro
Gly Trp Pro Ile
Gly Trp Pro Leu
His Cys Gly Arg
His Cys Arg Gly
His Gly Cys Arg
His Gly Lys Met
His Gly Met Lys
His Gly Arg Cys
His Lys Gly Met
His Lys Met Gly
His Lys Ser Thr
His Lys Thr Ser
His Met Gly Lys
His Met Lys Gly
His Asn Thr Thr
His Gln Ser Thr
His Gln Thr Ser
His Arg Cys Gly
His Arg Gly Cys
His Ser Lys Thr
His Ser Gln Thr
His Ser Thr Lys
His Ser Thr Gln
His Thr Lys Ser
His Thr Asn Thr
His Thr Gln Ser
His Thr Ser Lys
His Thr Ser Gln
His Thr Thr Asn
Ile Asp Pro Gln
Ile Asp Gln Pro
Ile Glu Asn Pro
Ile Glu Pro Asn
Ile Gly Pro Trp
Ile Gly Trp Pro
Ile Asn Glu Pro
Ile Asn Pro Glu
Ile Pro Asp Gln
Ile Pro Glu Asn
Ile Pro Gly Trp
Ile Pro Asn Glu
Ile Pro Gln Asp
Ile Pro Trp Gly
Ile Gln Asp Pro
Ile Gln Pro Asp
Ile Trp Gly Pro
Ile Trp Pro Gly
Lys Gly His Met
Lys Gly Met His
Lys His Gly Met
Lys His Met Gly
Lys His Ser Thr
Lys His Thr Ser
Lys Met Gly His
Lys Met His Gly
Lys Asn Asn Pro
Lys Asn Pro Asn
Lys Pro Asn Asn
Lys Ser His Thr
Lys Ser Thr His
Lys Thr His Ser
Lys Thr Ser His
Leu Asp Pro Gln
Leu Asp Gln Pro
Leu Glu Asn Pro
Leu Glu Pro Asn
Leu Gly Pro Trp
Leu Gly Trp Pro
Leu Asn Glu Pro
Leu Asn Pro Glu
Leu Pro Asp Gln
Leu Pro Glu Asn
Leu Pro Gly Trp
Leu Pro Asn Glu
Leu Pro Gln Asp
Leu Pro Trp Gly
Leu Gln Asp Pro
Leu Gln Pro Asp
Leu Trp Gly Pro
Leu Trp Pro Gly
Met Gly His Lys
Met Gly Lys His
Met His Gly Lys
Met His Lys Gly
Met Lys Gly His
Met Lys His Gly
Met Pro Pro Gln
Met Pro Gln Pro
Met Gln Pro Pro
Asn Glu Ile Pro
Asn Glu Leu Pro
Asn Glu Pro Ile
Asn Glu Pro Leu
Asn His Thr Thr
Asn Ile Glu Pro
Asn Ile Pro Glu
Asn Lys Asn Pro
Asn Lys Pro Asn
Asn Leu Glu Pro
Asn Leu Pro Glu
Asn Asn Lys Pro
Asn Asn Pro Lys
Asn Asn Pro Gln
Asn Asn Gln Pro
Asn Pro Glu Ile
Asn Pro Glu Leu
Asn Pro Ile Glu
Asn Pro Lys Asn
Asn Pro Leu Glu
Asn Pro Asn Lys
Asn Pro Asn Gln
Asn Pro Gln Asn
Asn Gln Asn Pro
Asn Gln Pro Asn
Asn Thr His Thr
Asn Thr Thr His
Pro Ala Glu Arg
Pro Ala Arg Glu
Pro Ala Val Trp
Pro Ala Trp Val
Pro Cys Pro Arg
Pro Cys Arg Pro
Pro Asp Ile Gln
Pro Asp Leu Gln
Pro Asp Gln Ile
Pro Asp Gln Leu
Pro Glu Ala Arg
Pro Glu Ile Asn
Pro Glu Leu Asn
Pro Glu Asn Ile
Pro Glu Asn Leu
Pro Glu Gln Val
Pro Glu Arg Ala
Pro Glu Val Gln
Pro Gly Ile Trp
Pro Gly Leu Trp
Pro Gly Trp Ile
Pro Gly Trp Leu
Pro Ile Asp Gln
Pro Ile Glu Asn
Pro Ile Gly Trp
Pro Ile Asn Glu
Pro Ile Gln Asp
Pro Ile Trp Gly
Pro Lys Asn Asn
Pro Leu Asp Gln
Pro Leu Glu Asn
Pro Leu Gly Trp
Pro Leu Asn Glu
Pro Leu Gln Asp
Pro Leu Trp Gly
Pro Met Pro Gln
Pro Met Gln Pro
Pro Asn Glu Ile
Pro Asn Glu Leu
Pro Asn Ile Glu
Pro Asn Lys Asn
Pro Asn Leu Glu
Pro Asn Asn Lys
Pro Asn Asn Gln
Pro Asn Gln Asn
Pro Pro Cys Arg
Pro Pro Met Gln
Pro Pro Gln Met
Pro Pro Arg Cys
Pro Gln Asp Ile
Pro Gln Asp Leu
Pro Gln Glu Val
Pro Gln Ile Asp
Pro Gln Leu Asp
Pro Gln Met Pro
Pro Gln Asn Asn
Pro Gln Pro Met
Pro Gln Val Glu
Pro Arg Ala Glu
Pro Arg Cys Pro
Pro Arg Glu Ala
Pro Arg Pro Cys
Pro Val Ala Trp
Pro Val Glu Gln
Pro Val Gln Glu
Pro Val Trp Ala
Pro Trp Ala Val
Pro Trp Gly Ile
Pro Trp Gly Leu
Pro Trp Ile Gly
Pro Trp Leu Gly
Pro Trp Val Ala
Gln Asp Ile Pro
Gln Asp Leu Pro
Gln Asp Pro Ile
Gln Asp Pro Leu
Gln Glu Pro Val
Gln Glu Val Pro
Gln His Ser Thr
Gln His Thr Ser
Gln Ile Asp Pro
Gln Ile Pro Asp
Gln Leu Asp Pro
Gln Leu Pro Asp
Gln Met Pro Pro
Gln Asn Asn Pro
Gln Asn Pro Asn
Gln Pro Asp Ile
Gln Pro Asp Leu
Gln Pro Glu Val
Gln Pro Ile Asp
Gln Pro Leu Asp
Gln Pro Met Pro
Gln Pro Asn Asn
Gln Pro Pro Met
Gln Pro Val Glu
Gln Ser His Thr
Gln Ser Thr His
Gln Thr His Ser
Gln Thr Ser His
Gln Val Glu Pro
Gln Val Pro Glu
Arg Ala Glu Pro
Arg Ala Pro Glu
Arg Cys Gly His
Arg Cys His Gly
Arg Cys Pro Pro
Arg Glu Ala Pro
Arg Glu Pro Ala
Arg Gly Cys His
Arg Gly His Cys
Arg His Cys Gly
Arg His Gly Cys
Arg Pro Ala Glu
Arg Pro Cys Pro
Arg Pro Glu Ala
Arg Pro Pro Cys
Ser His Lys Thr
Ser His Gln Thr
Ser His Thr Lys
Ser His Thr Gln
Ser Lys His Thr
Ser Lys Thr His
Ser Gln His Thr
Ser Gln Thr His
Ser Thr His Lys
Ser Thr His Gln
Ser Thr Lys His
Ser Thr Gln His
Thr His Lys Ser
Thr His Asn Thr
Thr His Gln Ser
Thr His Ser Lys
Thr His Ser Gln
Thr His Thr Asn
Thr Lys His Ser
Thr Lys Ser His
Thr Asn His Thr
Thr Asn Thr His
Thr Gln His Ser
Thr Gln Ser His
Thr Ser His Lys
Thr Ser His Gln
Thr Ser Lys His
Thr Ser Gln His
Thr Thr His Asn
Thr Thr Asn His
Val Ala Pro Trp
Val Ala Trp Pro
Val Glu Pro Gln
Val Glu Gln Pro
Val Pro Ala Trp
Val Pro Glu Gln
Val Pro Gln Glu
Val Pro Trp Ala
Val Gln Glu Pro
Val Gln Pro Glu
Val Trp Ala Pro
Val Trp Pro Ala
Trp Ala Pro Val
Trp Ala Val Pro
Trp Gly Ile Pro
Trp Gly Leu Pro
Trp Gly Pro Ile
Trp Gly Pro Leu
Trp Ile Gly Pro
Trp Ile Pro Gly
Trp Leu Gly Pro
Trp Leu Pro Gly
Trp Pro Ala Val
Trp Pro Gly Ile
Trp Pro Gly Leu
Trp Pro Ile Gly
Trp Pro Leu Gly
Trp Pro Val Ala
Trp Val Ala Pro
Trp Val Pro Ala
MK 886
ETHYL 5-(2,4-BIS(BENZYLOXY)-5-ISOPROPYLPHENYL)ISOXAZOLE-3-CARBOXYLATE
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(2-methylphenyl)- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(3-methylphenyl)- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclohexylamino)-2-oxoethyl]-7-methyl-N-(4-methylphenyl)- (9CI)
Thieno[2,3-b]quinoline-2-carboxamide, N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,3-dimethylphenyl)-7-methyl- (9CI)
4-[5-(trans-4-Aminocyclohexylamino)-3-isopropylpyrazolo[1,5-A]pyrimidin-7-ylamino]-N,N-dimethylbenzenesulfonamide
Aganepag isopropyl
C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
2H-1-Benzopyran-7-ol, 3-(4-methoxyphenyl)-4-((4-(2-(1-piperidinyl)ethoxy)phenyl)methyl)-
2-amino-N-[5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
Ethanone, 1-(7,8-dihydro-2-((9-(trans-4-methylcyclohexyl)-9H-pyrido(4,3:4,5)pyrrolo(2,3-d)pyrimidin-2-yl)amino)-1,6-naphthyridin-6(5H)-yl)-2-hydroxy-
Zanubrutinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163774 - BTK-targeting Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents D006401 - Hematologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-amino-N-[(2R,3R,4S,5S)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
2-[3a-[1-(furan-3-yl)-5,8a-dimethyl-3-oxo-4,6,7,8-tetrahydro-1H-isochromen-6-yl]-2,2-dimethyl-6-oxo-3,4,7,7a-tetrahydrofuro[3,2-c]pyran-3-yl]acetate
Ansaetherone
An eleven-membered macrocyclic lactam that consists of (2S,3E,5Z,14S,15R)-5-ethylidene-11,14-dihydroxy-3,7,15-trimethyl-2,5-dihydro-2,13-ethano-1,9-benzoxazacycloundecine-6,8-dione in which the 14-hydroxy group is substituted by a (2R,5R,6R)-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl moiety. It is a radical scavenger isolated from Streptomyces.
Scutebarbatine G
A diterpene alkaloid of group of neo-clerodanes isolated from the whole plants of Scutellaria barbata and has been shown to exhibit neoplastic activity.
2-nitro-N-[[4-[(1,2,3,4-tetrahydronaphthalen-2-ylmethylamino)methyl]cyclohexyl]methyl]benzenesulfonamide
2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
N-[3-[butyl(ethyl)amino]propyl]-1-(9-fluoro-[1]benzothiolo[3,2-d]pyrimidin-4-yl)-4-piperidinecarboxamide
(2S)-2-amino-N-[(2S,3S,4R)-5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide
N-[(5R,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5R,6R,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
(2S,3S,3aR,9bR)-7-(1-cyclohexenyl)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-2-[4-morpholinyl(oxo)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
N-[(5R,6S,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6R,9R)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6R,9S)-5-methoxy-8-(2-methoxyacetyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
(2R,3R,3aS,9bS)-7-(cyclohexen-1-yl)-3-(hydroxymethyl)-1-(2-methoxyacetyl)-2-(morpholine-4-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-6-oxo-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
4-[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
(2S)-2-[(4S,5R)-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-8-(2-pyridin-4-ylethynyl)-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-2-yl]-1-propanol
N-[(5R,6R,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[(5S,6S,9S)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2R,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5R,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1S,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
(6R,7S,8S)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6R,7R,8S)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
4-[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
4-[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
3-[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
3-[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-5-[[methyl(propyl)amino]methyl]-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-8-yl]benzonitrile
N-[(5S,6S,9R)-5-methoxy-8-(2-methoxy-1-oxoethyl)-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide
N-[2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
N-[2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]ethyl]-1,3-benzodioxole-5-carboxamide
2-[(2S,5R,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6R)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2S,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(2R,5S,6S)-5-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-methoxyphenyl)methyl]acetamide
2-[(1R,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-6-[[2-(dimethylamino)-1-oxoethyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(3-fluorophenyl)methyl]acetamide
(6S,7S,8R)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
(6S,7S,8S)-8-(hydroxymethyl)-N-(2-methoxyphenyl)-7-[4-(3-methylphenyl)phenyl]-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
2-[[9-(1-Methylethyl)-6-[[3-(2-pyridinyl)phenyl]amino]-9H-purin-2-yl]amino]-1-butanol hydrochloride hydrate
(2S)-2-amino-N-[(2S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate
MK886
D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors